International Clinical Trial: Short-Course Hypofractionated Radiotherapy Combined with Irinotecan Liposome Injection (II) and Retlirafusp alfa in Advanced Refractory Solid Tumors

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132110) titled 'Short-Course Hypofractionated Radiotherapy Combined with Irinotecan Liposome Injection (II) and Retlirafusp alfa in Advanced Refractory Solid Tumors' on Sept. 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Drum Tower Hospital

Condition: Advanced refractory solid tumors

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-09-10

Target Sample Size: Combination Therapy Group:26;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=342648

Published by HT Digital Content Services with permission from Healt...